Funder
National Natural Science Foundation of China
Reference55 articles.
1. Pancreatic cancer surgery;Di Martino;BMC Surg.,2023
2. P.U.O.E. Tempero MA, Adjuvant nab-Paclitaxel 1 Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. J. Clin. Oncol. 41 (2023) 2007-2019, 10.1200/JCO.22.01134.
3. Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial;Conroy;JAMA Oncol.,2022
4. Increased glucose availability sensitizes pancreatic cancer to chemotherapy;Vaziri-Gohar;Nat. Commun.,2023
5. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer;Nevala-Plagemann;Nat. Rev. Clin. Oncol.,2020
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献